CNSY Cerenome, Inc. Common Stock

XNAS
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

CNSY — —
Key stats
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
28
List Date
2000-11-16
CIK
0001095981
Next Earnings
2026-10-29
EPS Forecast
($0.98) (1 est.)
Headquarters
Houston, TX
Homepage
https://www.cerenome.com

Cerenome Inc is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The da…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'26Avg
Jan----
Feb----
Mar----
Apr----
May----
Jun----
Jul----
Aug-19.89%-19.89%
Sep-31.00%-31.00%
Oct-11.80%*-11.80%
Nov----
Dec----
Total-51.25%-51.25%
* Only 1 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $1.72
SMA 50: $2.23
SMA 200: —
Current: $1.57
EMA 12: $1.71
EMA 26: $1.87
MACD: -0.1661 | Signal: 0.0324
BEARISH
ADX (14): 15.94
RANGE
+DI: 20.24
−DI: 23.89

Momentum Oscillators

RSI (14): 36.59
NEUTRAL
Stoch %K: 30.98
Stoch %D: 39.56
Williams %R: -86.67

Volume & Volatility

BB Upper: $1.94
BB Lower: $1.51
NEUTRAL
OBV: -2,348,746
Vol SMA 20: 167,727
Vol ROC: 41.32%
ATR: $0.19
True Range: $0.14
HV 20: 96.0%
HV 30: 87.2%
HV 60: —

Data Summary

Data Points: 60
Last Updated:
Date Range: 2026-08-03T00:00:00 – 2026-10-26T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All CNSY news →

CNSY Options Activity & IV Rank

Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
ATM — / Wing —
30 DTE / 10d —
— pts EXTREME
ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis

Risk Metrics

Beta: 3.0718
Alpha: -323.11%
Correlation: 0.3691
R-Squared: 13.6%
Stock Volatility: 83.4%
Market Volatility: 10.0%

Analysis Details

Benchmark: SPY
Data Points: 59
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own CNSY
1 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Citadel Hedge fund
Ken Griffin
$112K
0.00%
#5750 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

CNSY Institutional Ownership (13F)

Latest filings — 2026-09-30

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

22 filers660,902 shares$2.89M value
# Filer Shares Value % of Total % of Float Period
1 Vanguard Capital Management LLC 304,745 $1.33M 46.14% — 2026-06-30
2 BlackRock, Inc. Custodian 95,983 $419.45K 14.53% — 2026-06-30
3 Geode Capital Management, LLC Custodian 76,155 $332.94K 11.53% — 2026-06-30
4 Vanguard Fiduciary Trust Co 36,868 $161.11K 5.58% — 2026-06-30
5 Ashton Thomas Private Wealth, LLC 34,306 $149.92K 5.19% — 2026-06-30
6 State Street Corp 30,853 $134.83K 4.67% — 2026-06-30
7 Citadel Advisors LLC Custodian 25,597 $111.86K 3.88% — 2026-06-30
8 Northern Trust Corp Custodian 15,516 $67.81K 2.35% — 2026-06-30
9 Virtu Financial LLC 15,343 $67.00K 2.32% — 2026-06-30
10 HRT FINANCIAL LP 11,612 $50.00K 1.73% — 2026-06-30
11 Wells Fargo & Company Custodian 6,156 $26.90K 0.93% — 2026-06-30
12 Vanguard Global Advisers, LLC 2,282 $9.97K 0.35% — 2026-06-30
13 OSAIC HOLDINGS, INC. Custodian 2,000 $8.74K 0.30% — 2026-06-30
14 Tower Research Capital LLC (TRC) Custodian 1,955 $8.54K 0.30% — 2026-06-30
15 UBS Group AG Custodian 470 $2.05K 0.07% — 2026-06-30
16 Allied Private Wealth LLC 496 $1.89K 0.07% — 2026-06-30
17 Morgan Stanley Custodian 185 $808 0.03% — 2026-06-30
18 SBI Securities Co., Ltd. 251 $469 0.02% — 2026-09-30
19 Barclays PLC Custodian 96 $420 0.01% — 2026-06-30
20 Citigroup Inc. Custodian 17 $74 <0.01% — 2026-06-30
21 Caitong International Asset Management Co., Ltd 12 $52 <0.01% — 2026-06-30
22 Global Retirement Partners, LLC 4 $17 <0.01% — 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

CNSY Insider Trading (Form 4)

Latest: 2026-10-01
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-01 Richard J Hawkins Director Exer (M) +921 — EDGAR
2026-10-01 Kyle Guse Director Exer (M) +921 — EDGAR
2026-10-01 Andrew John Hugh MacIntyre Sims Chief Financial Officer Exer (M) +2,985 — EDGAR
2026-10-01 Ronald Asbury Andrews Director Exer (M) +921 — EDGAR
2026-10-01 Marc H Hedrick Chief Executive Officer Exer (M) +16,439 — EDGAR
2026-10-01 Howard Clowes Director Exer (M) +921 — EDGAR
2026-10-01 An van Es-Johansson Director Exer (M) +921 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

CNSY Insider Holdings

7 insiders · @ $1.57
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Marc H Hedrick Chief Executive Officer 60,922 $95.6K $0 1 2026-10-01
2 Andrew John Hugh MacIntyre Sims Chief Financial Officer 12,926 $20.3K $0 1 2026-10-01
3 Howard Clowes Director 2,902 $4.6K $0 1 2026-10-01
4 Richard J Hawkins Director 2,450 $3.8K $0 1 2026-10-01
5 Ronald Asbury Andrews Director 1,843 $2.9K $0 1 2026-10-01
6 Kyle Guse Director 1,843 $2.9K $0 1 2026-10-01
7 An van Es-Johansson Director 1,843 $2.9K $0 1 2026-10-01
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

CNSY Board & Officers

As of SEC filings through Oct 1, 2026

Directors 6

Officers 3

Changes in the last 10 years (20)
Apr 20, 2026Eric Joseph Daniels became Chief Development Officer
Mar 20, 2026The company announced the departure of Robert P Lenk from the board in an SEC filing
Mar 20, 2026Ronald Asbury Andrews became a director
Apr 18, 2025The company announced the departure of Greg Petersen from the board in an SEC filing
Apr 18, 2025Kyle Guse became a director
Jun 5, 2024The company announced the departure of Norman D. LaFrance as Chief Medical Officer in an SEC filing
Nov 11, 2021Norman D. LaFrance became Chief Medical Officer
Dec 14, 2020Marc H Hedrick first listed as a director in an SEC filing
Jun 23, 2020Marc H Hedrick listed as Chief Executive Officer (previously President and CEO) in SEC filings
Apr 1, 2020Robert P Lenk became a director
Apr 1, 2020Howard Clowes became a director
Feb 14, 2020Greg Petersen became a director
Feb 5, 2020Andrew John Hugh MacIntyre Sims became Chief Financial Officer
Jan 1, 2020An van Es-Johansson became a director
Jul 27, 2018Marc H Hedrick no longer listed as a director in SEC filings
Feb 15, 2018PostFinance AG reported in an SEC filing no longer being a 10% owner
Jan 25, 2018PostFinance AG became a 10% owner
Dec 29, 2017Swissquote Bank SA became a 10% owner
Mar 31, 2017Anthony Gregg Lapointe became a director
Dec 27, 2016Ron Martell became a director
Not reported recently (11)
  • Tiago Girao · Last reported as VP & Chief Financial Officer in an SEC filing dated Jul 27, 2018
  • Gary A Lyons · Last reported as a director in an SEC filing dated Feb 9, 2018
  • Swissquote Bank SA · Last reported as a 10% owner in an SEC filing dated Jan 11, 2018
  • David Rickey · Last reported as a director in an SEC filing dated Nov 29, 2017
  • Gail K Naughton · Last reported as a director in an SEC filing dated Nov 29, 2017
  • John David Harris · Last reported as VP and GM Cell Therapy in an SEC filing dated Nov 29, 2017
  • Anthony Gregg Lapointe · Last reported as a director in an SEC filing dated May 24, 2017
  • Jeremy B. Hayden · Last reported as General Counsel & VP of BD in an SEC filing dated Mar 17, 2017
  • Mark Marino · Last reported as Chief Medical Officer in an SEC filing dated Mar 17, 2017
  • Paul W Hawran · Last reported as a director in an SEC filing dated Jan 27, 2017
  • Ron Martell · Last reported as a director in an SEC filing dated Jan 27, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

CNSY Proposed Insider Sales (Form 144)

Latest: 2025-05-07
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2025-05-07 Petersen Greg Director 36,666 — 2025-05-15 Vanguard Marketing Corporation — EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
3 ETFs hold CNSY
3 shown · $612.30K total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $408,595 — 2026-09-30
2 VXF Vanguard Extended Market ETF Vanguard 0.00% $161,278 — 2026-09-30
3 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.00% $42,428 $1.2B 2026-10-23
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.